Home › Colite ulcerosa › Louisiana
Studi clinici su Colite ulcerosa nello stato di Louisiana
15 studi su Colite ulcerosa cercano partecipanti presso sedi nello stato di Louisiana.
Città nello stato di Louisiana
Testo ufficiale dello studio (inglese)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastro Group and Endocenter: Mandeville, la /ID# 284186, Mandeville
- Metropolitan Gastroenterology Associates - Metairie /ID# 283922, Metairie
- Willis-Knighton Medical Center /ID# 280572, Shreveport
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Baton Rouge General Medical Center - Bluebonnet Campus, Baton Rouge
- Combined Gastro LLC, Lafayette
- GI Alliance, Metairie
In reclutamentoFase 4
Età da 18 a 80 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Clinical Trials Management, LLC, Metairie
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 035, Marrero
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-008, Baton Rouge
- Site US-011, Mandeville
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073), New Orleans
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Delta Research Partners, LLC, West Monroe
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Care Access - New Iberia, New Iberia
- Louisiana Research Center, Shreveport
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Gastro Group and Endocenter - Mandeville, Mandeville
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- GI Alliance, Metairie
- Tulane University, New Orleans
In reclutamentoFase 4
Età da 18 a 65 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
- Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville - Site Number: 8400128, Mandeville
- Delta Research Partners - Site Number: 8400087, Monroe
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07185009A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Clinic of Acadiana, Lafayette
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
- Tandem Intermediate, LLC - Houma -Site Number: 8400034, Houma
- GastroGroup - Site Number: 8400128, Mandeville
- e altri 4
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07184996A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Lafayette
- Mirador Therapeutics Selected Site, Marrero
- Mirador Therapeutics Selected Site, Shreveport
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT07113522Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- Tulane University, New Orleans
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 mag 2025 · NCT06750731Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.